Four-Month Rifapentine Regimens for Tuberculosis. Reply

N Engl J Med. 2022 Mar 17;386(11):1095-1096. doi: 10.1056/NEJMc2114483.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Rifampin* / analogs & derivatives
  • Rifampin* / therapeutic use
  • Tuberculosis* / drug therapy

Substances

  • Rifampin
  • rifapentine